<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The purpose of this EP wire survey was to assess clinical practice in relation to the use of left atrial appendage occlusion (LAAO) devices for <z:hpo ids='HP_0001297'>stroke</z:hpo> prevention in <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> (AF) among members of the European Heart Rhythm Association research network </plain></SENT>
<SENT sid="1" pm="."><plain>The average number of performed LAAO was 10.6 per year and most (73%) centres performed â‰¤10 procedures per year </plain></SENT>
<SENT sid="2" pm="."><plain>We found that LAAO was being performed for <z:hpo ids='HP_0001297'>stroke</z:hpo> prevention in AF, for the most common indication being 'the patient has absolute contraindication to long term oral <z:chebi fb="2" ids="50249">anticoagulants</z:chebi>' </plain></SENT>
<SENT sid="3" pm="."><plain>Among survey respondents, LAAO procedures are most often performed by interventional cardiologists </plain></SENT>
<SENT sid="4" pm="."><plain>Experience varied widely, and this was reflected in the wide range of thromboembolic and procedural (tamponade, <z:mp ids='MP_0001914'>bleeding</z:mp>) complications reported by the respondents to this EP wire survey </plain></SENT>
</text></document>